Esketamine Reduces Long-Term Relapse in Treatment-Resistant Depression - MD Magazine

Submitted by Anonymous (not verified) on Wed, 06/05/2019 - 15:13

Esketamine Reduces Long-Term Relapse in Treatment-Resistant Depression  MD MagazineThe nasal spray was shown to reduce relapse in patients who achieved remission or stability after 16 weeks of treatment plus antidepressant.